On the Interface of Intellectual Property and Antitrust: The Case of Divisional Patent Applications in the Pharmaceutical SectorClient Updates
Fifth Circuit Hands FTC Win in FTC’s First Fully-Litigated Reverse-Payment Case Following the Supreme Court’s Landmark Actavis DecisionClient Updates
The AIPLA Antitrust News, AIPLA Committee on Antitrust Law
Reverse Payments and Beyond: Antitrust Risks for Pharmaceutical and Biotechnology Companies Amid Heightened Scrutiny of Prescription Drug PricingExternal Article
American Health Lawyers Association PG Briefing
The FDA’s and FTC’s Increased Focus on Generic Drug Competition Signals Enhanced Attention to REMS IssuesExternal Article
ABA’s Antitrust Health Care Chronicle
Global Competition Review will host its international conference titled “GCR Live 7th Annual Antitrust Law Leaders Forum” from Friday, February 2nd to Saturday, February 3rd in Miami, Florida.